Method (references) | Positive effecta | Application | Remarks |
---|---|---|---|
Yes | Â | No randomized data, increase in CFI. | |
External counterpulsation [47] | Yes | Â | One randomized controlled trial (RCT), observational studies, increase in CFI, improvement of angina symptoms |
Yes | Intracoronary, subcutaneous | Two small RCTs (n = 21, n = 12). Stopped early because of potential plaque destabilization. Increase in CFI. | |
G-CSF [44] | Yes | Subcutaneous | One small randomized trial (n = 52). Increase in CFI. |
Dipyridamole [53] | Yes | Â | Very small trial (n = 30); angiographic collateral assessment, which is not very accurate |
VEGF [54] | No | Intracoronary | No difference in angina symptoms or exercise tolerance |
FGF4 (adenovirus) [55] | No | Intracoronary | No change in exercise tolerance |